ILA - Island Pharmaceuticals Limited - Strawman: ASX share price, valuation, research and discussion

Reports (2) My Report Forum Investors

Top member reports

Consensus

No meetings

Consensus community valuation

XXXXXX

Average Intrinsic Value

XXXXXX

Undervalued by

The consensus valuation is for members only and has been removed from this chart. Click for membership options.

Become a member

Contributing Members

Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.

Become a member

Valuation of $0.475

spacetimetrave

Added 2 months ago

Great spotting @RMKD !

Valuation is driven by the massive arbitrage opportunity of the Priority Review Voucher (PRV), which is worth approximately AUD $230M (roughly double the company's current market cap approximately AUD $115M) and would be awarded upon FDA approval

De-risked by 'Animal Rule' and Texas Biomed partnership

#Bull Case

RMKD

Added 2 months ago

Island Pharmaceuticals Limited

Island Pharmaceuticals Limited

Set Price Alert for ILA

Consensus community valuation

Contributing Members

Place trade